CD274 and idiopathic pulmonary fibrosis: The potential role of the PD-1/PD-L1 immune checkpoint in IPF was observed, and a series of preclinical studies were initiated in the hope that this new anti-tumor drug could bring a promising future to the treatment of IPF.